Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer. Clinical epigenetics. 2015;7(1):74.
Large differences in global transcriptional regulatory programs of normal and tumor colon cells. BMC cancer. 2014;14:708.
Molecular monitoring of epithelial-to-mesenchymal transition in breast cancer cells by means of Raman spectroscopy. Biochimica et biophysica acta. 2014;1843(9):1785-95.
Use of text-message reminders to improve participation in a population-based breast cancer screening program. Journal of medical systems. 2014;38(9):118.
A Monotonic and Prognostic Genomic Signature from Fibroblasts for Colorectal Cancer Initiation, Progression and Metastasis. Molecular cancer research : MCR. 2014.
A genome-wide association study on copy-number variation identifies a 11q11 loss as a candidate susceptibility variant for colorectal cancer. Human genetics. 2014;133(5):525-34.
Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer. Molecular cancer. 2014;13(1):46.
Genetic Variants and Multiple Myeloma Risk: IMMEnSE Validation of the Best Reported Associations--An Extensive Replication of the Associations from the Candidate Gene Era. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2014.
Comprehensive molecular characterisation of hereditary non-polyposis colorectal tumours with mismatch repair proficiency. European journal of cancer (Oxford, England : 1990). 2014;50(11):1964-72.